DrChi PART 1 October3

FINGERNAIL AND
TONGUE ANALYSIS
Heart, Hormones and Cancer
October 3, 2014 Anchorage, Alaska
Tsu-Tsair Chi, NMD, PhD

(714) 777-1542
Copyright. Chis Enterprise, Inc.

Continued Lecture
Sunday, October 5, 1:30 pm
Review of Heart and Hormones
Fingernail and Tongue Analysis for
Digestion, Liver, Kidneys, Lungs,
Mental Health, Skin, Autoimmune
Conditions

CONTACT
CHIS ENTERPRISE, INC.
1435 N. Brasher Street
Anaheim, CA 92807
(714) 777-1542
www.chi-health.com

2010 Hardcover
edition
Over 120 color
pictures

Jonathan Wright, MD from WA, writing Returning
to the Roots of Medicine in the preface of Dr. Chis
Fingernail and Tongue Analysis book:
the reemergence of interest in hands on

physical diagnosis together with extensive
knowledge of the body systems in health and
disease known by the modern physician
Having learned the fingernail and tongue method
from the master, Dr. Chi, I intend to use it
everyday in my practice.

D. Williams, MD from GA, suggests that
all doctors learn the CHI system for the
following reasons:
Make your analysis skills quicker and more effective
Save a lot of clinic time and avoid malpractice
Avoid unnecessary and expensive tests, improve your
provider profile
Observe critical health problems earlier
The system is low cost and easy to use

Cases detected by F& T Analysis
(2001- 2013)*
Type Cases
Cancer 228+
Heart/Bypass 54+
And more
* Later verified by medical tests

1,970+ Cases successfully improved by
Dr. Chis formulas (2001 2013)
Type Cases Type Cases
Hormone 360+ Immunity/Infection 52+
Cancer 295+ Heavy Metals 46+
Cardiovascular 205+ Anxiety/Sleep 45+
Weight Loss 130+ Thyroid 38+
Kidney/Bladder 118+ Osteoporosis 36+
Respiratory 112+ Rheumatoid Arthritis 32+
Skin 108+ Depression/Bipolar 28+
Digestive 82+
Fibromyalgia 15+
Liver/Gallbladder 80+
Eye 4
Pain 68+
Others 60+
Diabetes 56+

LUNULA

TEETH
MARKS

2008 Edition

Herbal Supplement Use Statistics
72% physicians and 89% nurses use dietary

supplements personally
79% physicians and 82% nurses
recommend dietary supplements to their
patients
Life supplemented Healthcare
Professionals Impact Study 2007

Reasons for Using CAM Therapies
Combination of CAM and conventional
55% treatments will help them
50% Interested to try CAM
Conventional medicine would not help

25% them
Women
CAM use People with higher education
was greater
Individuals hospitalized within the past year
among:
Former smokers
Complementary and Alternative Medicine (CAM)

Top Consumer Health Concerns(2006)
Extremely/ Extremely/
Condition Condition
Very Concerned Very Concerned
Heart Disease 58% High
46%
Cancer 57% cholesterol
Lack of Hypertension 45%
50%
Energy Lack of Mental
43%
Eye Health 48% Sharpness
Stress 47% Diabetes 43%
Arthritis/Pain 47% Depression 40%
Copyright. Chis Enterprise, Inc. 15

Essential factors for better
Herbal Production
Where to grow and when to harvest the herbs
Organic farms: no heavy metal and chemical
contamination
Standardized formula
GMP facility to process and purify the herbs
Sterilize the products during purification process
No need for fumigation and radiation

Reasons for Standardization and
Purification
Herbs have multiple functions
Standardization/Purification needed to
maximize herb effects
Astragalus Smilax
Immunity Liver
Lung Stomach
Heart Detox
Improves chi UTI
Tumors/fibroids

WHAT IT MEANS TO ME

TONGUE DIAGNOSIS
Color
Vitality
Moisture
Shape
Coating

Tongue Color
1. Pink tongue
2. Pale tongue
3. Red tongue
4. Dark red/Purple

Pink Tongue:
Normal
Light coating
on root of the
tongue

Pale Tongue:
Anemia
Shiny areas on
tongue: Anemia

Red Tongue:
Fever, Heart,
Infection
Spiky tongue:
Real fever

Dark Red or
Purple Tongue:
Blood stasis,
Serious

TONGUE DIAGNOSIS
KIDNEY
LIVER
GALLBLADDER SPLEEN LIVER
STOMACH
(GI)
LUNG LUNG

HEART
STOMACH
ULCER
Cracks on
tongue

Hypoglycemia
Teeth Marks
Lung
White Coating

SPIKY TONGUE
Tip Heart/Lung
Side Liver/Gallbladder
Center Stomach/Intestine

Bronchitis

Roadmap-like Tongue
Younger People:
Deficiency of Blood,
Hormone and Chi
Older People:
Digestion, Lack of
stomach acid

FEVER
Spikes

Tongue Ulcer, Pemphigoid or Cancer
If present for more than a month


Tongue Movement vs. Diseases
Stiff tongue and movement not easy
Stroke or cognition
Deviated tongue
Whiplash, heavy metals, and stroke
Tongue shrinks and is difficult to stick out
Very serious condition
Unable to control tongue, slow movements
and/or tongue hangs out:
Low IQ (since childhood) or stroke

Tongue Coating
Light white: Normal
White: Lung
Yellow: Stomach
Black: Digestion, Kidney, etc.

Distribution of Coating
Root / No Root
Wet / Dry
Greasy / Not Greasy
Grow / Reduce
Thick / Thin

FEVER or
LOCAL
INFLAMMATION:
Stomach
Yellowish/White
Coating

DIGESTION
Yellow
Coating

DIGESTION
KIDNEY
Black Coating

LIVER
Black, Dry,
Spiky Coating

Mirror-Like Tongue (Slippery)
Low serum
albumin

SNOW-LIKE
COATING
Autoimmune
Disease, etc.

Coating with
No Root
Serious
Condition

Peeling
Coating
Illness becomes
serious

SHAPE OR
GROWTH
CHANGE
NAIL CLUBBING
Sign of:
Heart problem
Lung disease
Cancer
Parasites
Digestive
Caused by low oxygen levels in problem
the blood

KOILONYCHIA (spoon nails)
Anemia Copyright. Chis Enterprise, Inc.

BEAUS LINES
Horizontal indentations across the nails
Nail growth is
interrupted by
severe illness
(heart attack) or
Copyright. Chis Enterprise, Inc. malnutrition

Copyright. Chis Enterprise, Inc. PITTING
Psoriasis
Chronic
Dermatitis
Yeast
infection
Alopecia
areata
Small
(hair loss)
depressions

ONYCHOLYSIS
Nail separates from nail bed Psoriasis
Injury
Thyroid
disease
Fungal
disease
Drug
reactions

TRIANGULAR NAILS
Bone marrow/Blood disease

COLOR
CHANGE

TERRYS NAILS (White nails)
Opaque nails with a dark band on tip
Cancer
Congestive
Heart failure
Diabetes
Liver disease
(cirrhosis)
Auto-immune
disease

MUEHRCKES LINES
Kidney
Disease
Transverse lines of discoloration that do not grow
with nails (on the nail bed)
MEES LINES
Kidney
Failure
Chemotherapy
Heavy metal
toxicity
Transverse lines of discoloration that grow with nails

Dark
longitudinal
streak(s)
Melanoma
Benign
Copyright. Chis Enterprise, Inc. nevus

HALF and HALF NAILS
Renal Failure
RED
LUNULA
Heart Disease
Systemic Lupus
Erymathosus
(SLE)
Rheumatoid
Copyright. Chis Enterprise, Inc. Arthritis

AZURE LUNULA
Silver poisoning, Wilsons disease,

quinachrine therapy
CARDIOVASCULAR

Cardiovascular Markers
Copyright. Chis Enterprise, Inc. Copyright. Chis Enterprise, Inc.
Nail Clubbing Ear Crease

Lung/Heart (> 50-60%) Heart (89%)

Cardiovascular Symptoms
Tip of tongue is red, ear crease, nail
Heart Disease
clubbing, lunulae on pinky
Lack of lunulae, cold hands & feet,
Poor Circulation numbness of the limbs (If the condition
improves, the lunulae should reappear)
Peripheral Artery
Central nail canal (fir tree abnormality)
Disease
Stroke/Aneurysm Cherry angiomas on forehead
Protruding blue veins and/or red/black spots
Heavy Metals underneath the tongue. Sometimes there is a
metallic taste.

Red dots on tip of tongue

Earlobe crease

Nail Clubbing Lung/Heart

Lunula on pinky, Horizontal ridges
(Heart Condition)
Lunula on the pinky

Heart Condition
Horizontal ridges

Peripheral Artery Disease
Central Nail Canal
Fir Tree abnormality

Stroke/Aneurysm
Cherry Angiomas on Forehead
Cherry angiomas on
forehead,
Family history of
stroke/aneurysm, and
Hypertension
Risk is 23 = 8x higher
than average people Copyright. Chis Enterprise, Inc.

L. Swerdloff,
MD from CA,
has a female
patient with
cherry angiomas
on the blood
vessels on her
forehead. She
reveals that she Copyright. Chis Enterprise, Inc.
had a stroke.

CORONARY HEART DISEASE

Blood pools
in the heel

Protocol for Cardiovascular Conditions
Vein Lite
OxyPower
Asparagus Extract
Hypertine
Wine Extract
Metal Flush

Main ingredients:
Salvia, Carthamus
Reference: Townsend Letter. June 2009; 311: 86-88.

VEIN LITE 1 of 2
for Cardiovascular Conditions
Salvia Carthamus
Removes
blood stasis Activates
Promotes blood
blood flow circulation
Angina Removes
blood stasis
Heart
Pain

VEIN LITE 2 of 2
for Cardiovascular Conditions
Paeonia Ligusticum
Numbness Promotes
Nourishes flow of
blood blood
Stomach/GI Relieves
Autoimmune pain

VEIN LITE on
CARDIOVASCULAR PATIENTS (30days)
40 38.1 36.8 38.1
130 patients
35
28.9
Red blood cell aggregation
Index of thromblastrogram
30 26.6
25
20
Microcirculation
Blood viscosity
15
Fibrrinogen
10
0
Journal of West China University of Medical Sciences. 1999;30:64.
Vein Lite on Cardiovascular
Symptoms of 300 Patients
Symptom 2 weeks 4 weeks 6 weeks 8 weeks
Headache 38.5 69.2 72.7 91.7
Dizziness 40.0 65.0 --- 66.7
Cardiac Flutter 57.1 71.4 75.2 80.0
Cold Hands/Feet 12.5 37.5 --- 53.3
Numb Hands/Feet 11.1 50.0 --- 55.5
1991 Japan Health Department

CASE REPORT
W. Smith, DC from CA, has a 55 y/o/f

patient who had difficulty concentrating,
slurred speech and numbness in the
limbs. She relates that taking Vein Lite
helps circulate the blood throughout the
body. Her focus is much better. She no
longer has numbness and slurred speech.

CASE REPORT
N.P. from TX has been taking Vein Lite,

Wine Extract for cardiovascular issues. After
1 years, her fibrinogen and cholesterol
levels reduced.
After
Before Reference
1 years
Fibrinogen 463 412 200-400 mg/dL
HDL Cholesterol 40 50 >45 mg/dL
Triglycerides >150 118 < 100 mg/dL
Total Cholesterol 250 204 <200 mg/dL

OxyPower for Cardiovascular Disease
Inflammation/C-Reactive
Protein (CRP)
Repairs/Protects vascular
endothelial cells from free
radical damage
Ejection fraction of heart LD50 > 40 ml/kg
DNA repair
Ingredients: Hippophae, Rhodiola
Mitochondrial efficacy

OXYPOWER
For Heart, Lung, Energy
Hippophae Rhodiola
Heart Heart
Lung Lung
Fatigue Fatigue
DNA
repair

OxyPower
Trilinolein
Active constituent of OxyPower
EPA
Eicosapentaenoic Acid (20:5)
DHA
Docosahexaenoic Acid (22:6)

CARDIOVASCULAR
DISEASE / STROKE / COPD /
ATHEROSCLEROSIS ASHTMA
DIABETES / INFLAMMATION
INSULIN CANCER
OXYPOWER
RESISTANCE
DEMENTIA / AUTOIMMUNE
ALZHEIMERS DISEASE DISEASE
ANTI-AGING
Sources: JAMA. 2013 Jun 12;309(22):2353-61 Heart. 2013 Aug;99(16):1192-7
Med Arh. 2013;67(3):160-1. J Am Coll Cardiol. 2013 May 30. pii:S0735-1097
Eur Heart J Cardiovasc Imaging. 2013 Jul 9 J Atheroscler Thromb. 2013 May 16

Chronic Inflammation/High CRP Conditions
CARDIOVASCULAR
Hypertension, atherosclerosis, stroke
High CRP causes CVD 4 to 5 times more than high
cholesterol
(CRP not only predicts atherosclerosis but also started signal
pathways that lead to atherosclerosis)
CANCER
Liver cancer induced by Hepatitis B or C
CRP also high in cervical cancer
AUTOIMMUNE DISEASE
ALZHEIMERS DISEASE
Inflammation damages brain arteries, neurons
CASE REPORT
P. Minkoff, MD from FL, has a 51 y/o/f patient

with high CRP level. After 3 months on
OxyPower, her CRP reduced significantly.
Serum test Before After 3 months Reference range

> 3.0, high
CRP 16 1.0
CVD risk

CASE REPORT
G. Depke, ND from CA, has a 67 y/o/f patient with

ischemia experiencing throbbing leg pain. Her
cholesterol and C-reactive protein (CRP) were both
high. She took OxyPower, Vein Lite, Asparagus
Extract and Wine Extract for 3-4 months.
Serum test Before After 3-4 months Reference range
Total Cholesterol 280 244 < 200 mg/dl
Cholesterol/HDL ratio 4.7 2.9 < 3.5, ideally

> 3.0, high CVD
C-Reactive Protein 4.1 1.7
risk

Left ventricle and Intima Media Thickness
important for overall circulation
Left ventricle pumps blood

into the system circulation
through the aorta
Intima Media
Thickness (IMT)
Inflammation - IMT

OxyPower Reduces
Left Ventricular Pressure
LVDP LVSP Heart rate
Group
(mmHg) (mmHg) (bpm)
CRP-Positive (CRP only) 10.67 163.5 398.3
Negative Control 6.14 177.3 377.5
OxyPower (CRP + OxyPower) 5.63 178.5 378.9
LVDP Left Ventricular Diastolic Pressure

LVSP Left Ventricular Systolic Pressure

OxyPower Reduces
Left Ventricular Hypertrophy*
( LVMI, IMT)
LVMI IMT
Group
(mg/g) (um)
CRP-Positive (CRP only) 2.35 + 0.29* 121.5 + 5.5
Negative Control 2.02 + 0.12 101.9 + 9.1
OxyPower (CRP +
2.04 + 0.11 101.9 + 7.4
OxyPower)
LVMI Left Ventricle Mass Index

IMT Intima Media Thickness

OxyPower reduces inflammation by 50%
in 7 days in Coronary Artery (IMT)
Endothelial Much
swelling narrower
Control group CoQ10 group OxyPower group
Inflammation can lead endothelial cells to break, causing scars and

plaque. Inflammation in the coronary artery and blood pressure
reduced with OxyPower.

CASE REPORT
An 84 y/o/m from CA had 100% blockage

on his left carotid artery due to narrowing of
the artery (stenosis). From March to April of
this year, he had 8 fainting spells even with
Coumadin. After he started taking OxyPower,
he never had a fainting spell again.

OxyPower reduces Inflammation
significantly in Heart Muscle Tissue
Control group CoQ10 group OxyPower group
White areas (above) signifies inflammation. With OxyPower,

inflammation in the heart muscle reduced (fewer white areas).

CASE REPORT
J.G., a 64 y/o/f from CA, has

congestive heart failure. Her
heart ejection fraction at the
time was 20 and had difficulty
breathing and driving. Then Copyright. Chis Enterprise, Inc.
she started taking OxyPower and Vein Lite for

6 months. Her heart ejection fraction gradually
increased from 20% to over 40%. Now she doesnt
need a pacemaker. Now she can breathe easier, has
no dizziness, has more energy and can drive.

All Cardiovascular Disease
involves Vascular Endothelial
Cell Damage
OxyPower provides
70% higher cell protection than
CoQ10 from Vascular
Endothelial Cell Damage
Reference: Townsend Letter. May 2011; 334:70-76
Copyright. Chis Enterprise, Inc. 97

CASE REPORT
L. McCoy, RPh: I have been taking Vein Lite

and OxyPower for 7 days...I noticed almost
immediately was the pain, burning, aching in
my lower legs that lessened about 50%. On a
scale of 1 to 10 with 10 being the worst pain in
my legs, I now stand at about a 3.

CASE REPORT
M. Rocco, DC from CO, has a 65 y/o/f patient with

mitral valve prolapse. Her doctor wanted her to have
a valve replacement 6 months before that. She has a
difficult time walking due to breathing problems.
She tried CoQ10 for a while but she didnt feel any
difference. When she took OxyPower and Vein Lite,
the results were so quick! She says that 1 hour after
taking OxyPower, she felt so amazing: no more
breathing difficulty and weakness. After 6 months,
doctor says she doesnt need a valve replacement.

ASPARAGUS EXTRACT
Best source of natural folate
Excellent alkalinizing agent
HEART homocysteine level
IMMUNITY IL-2, NK, CD4/CD8,
bone marrow, thymus, spleen,
phagocytosis
KIDNEY Renal glomerulus
reabsorption, natural diuretic agent
PREGNANCY prevents miscarriage
and neural tube defects

ASPARAGUS EXTRACT contains:
ORGANIC FOLATE
(9 capsules or 3 bags contains > 400 g of organic folate)
ASPARAGINASE
ASPARAGOSIDE
GLUTATHIONE
VITAMIN B, C, E
ORGANIC SELENIUM
ORGANIC ZINC
Asparagus Extract Improves
Cardiovascular Function
Natural diuretic (For hypertension)
Homocysteine level (CVD risk)
ACE inhibitor (For hypertension)
Carotid intima media thickness (IMT)
(For atherosclerosis, stroke)
Sources: Int J Cardiol. 2010; 143(1): 16-9.
Atherosclerosis. 2012; 222(2):307-13
J Agric Food Chem. 2013; 61(23):5520-5.

Asparagus Extract reduces Cardiovascular
Disease Risk by Reducing Homocysteine Levels
40 Normal
35 39% Homocysteine level
30 < 6 mol/L
% change
25
28% Homocysteine linked to
20
Heart disease
15
Cancer
10
Folic Acid Homocysteine Alzheimers Disease
5
(1 month) (4 months) Osteoporosis
0
The American Journal of Clinical Nutrition. 2002; 76(4):758-65.

JAMA. 2002; 288:973-979.

Xanthomas (eyelid plaque) may signal
Atherosclerosis, Ischemic Heart Disease,
Myocardial Infarction, High Cholesterol*
48% higher chance of myocardial infarction

If present in those under 30 years old,
signals arterial plaque
*British Medical Journal. 2011; 343:d5497.

Cholesterol
deposits
(47 y/o/m)
Arm
Knuckles Elbow

Wine Extract reduces cholesterol in
155 patients (3 months)
90
80 88%
80% 84%
70
Atherosclerosis Index
60 65%
Total Cholesterol
50
%
40
Triglycerides
30
20
10
0

CASE REPORT
J. Iannetta, DC from ME, has a female patient

who took Wine Extract for her elevated levels
of cholesterol and triglycerides.
After 1
Serum Test Before WE Reference
months on WE
Cholesterol 177 133 <200 mg/dl
HDL 37 42 >60 mg/dl
LDL 112 68 <100 mg/dl
Triglycerides 144 119 <150 mg/dl

Protocol for Hypertension
Hypertine
Asparagus Extract
Vein Lite
OxyPower

HYPERTINE
for Hypertension
Uncaria Cassia Prunella

Dizziness Dizziness
Kidney-
Hypertension Headaches
induced
Convulsions Liver hypertension
Eclampsia Vision
Constipation

Hypertine on 199 Hypertensive patients
(3 months)
45
Effective rate (%)
42.6
30
25.0
22.4
15
0
Effective Improved No Effect
The higher the blood pressure, the greater the reduction it produces
No effect on a person with normal blood pressure.

CASE REPORT
A. Khalaf, DC from FL, has a patient with blood pressure

ranging from 150/110 to 160/120 mmHg. He took Avapro
which reduced his blood pressure to around 150/90mmHg.
Then he added Hypertine and Asparagus Extract. After 1
month, his blood pressure became stable and he stopped
Avapro altogether.
After adding
No medication
Protocol With Avapro Hypertine and
or herbs
Asparagus
Up to
Blood pressure 150/90 mmHg 127/76 mmHg
160/120 mmHg

Heavy Metal Toxicity Symptoms
Black- or blue-colored nails

Dark, protruding veins under the
tongue with red/black spots
Gum shows dark/blue lines
Metallic taste in mouth

Blue veins under the tongue

Heavy metal deposit in gum


Silver and Copper Poisoning



Sources of Heavy Metals
Heavy Heavy
Source Source
Metal Metal(s)
Water Pb Amalgam Hg
Cigarettes Pb, Cd Fish Hg
Gasoline Pb Hair dye Cd
Paint Pb Deodorant Al
Plastic (Toys) Pb Cooking Utensils Al
Cosmetics Pb, Hg Vaccine Hg, Al
Al Aluminum Cd Cadmium Pb Lead Hg Mercury

METAL FLUSH 1 of 2
for Heavy Metal Toxicity
Smilax Sargassum
Liver Liver
Stomach Stomach
Detox Kidney
UTI Detox
Lymph
nodes

METAL FLUSH 2 of 2
for Heavy Metal Toxicity
Rheum Allium
Detox Anti-bacterial
Constipation Anti-parasitic
Liver CVD
GI Bleeding Cholesterol
Tumor

METAL FLUSH
Oral chelating herbal supplement
No Side Effects
Does not strip essential trace elements.
Safe for children (3 years and older) to take.
Kidney patients can take with Asparagus
Extract and use with Bathdetox
Removes heavy metals through urination and
fecal excretion
Inexpensive

Metal Flush on Lead Toxicity
0.8
0.7 110 Patients
0.725
Lead in Urine umole/L
0.6
0.5
0.4
0.3
0.2
0.1
0.097
0
1st day 10 days
(10 days is one course, 3 courses is a treatment period)

Usage: 3-4 capsules, 3 times a day.

Metal Flush vs. EDTA: Chelating Power
Pb2+ Cd2+ Hg2+ Zn2+

EDTA ++++ ++++ ++++
Metal
++++ +++ +++
Flush
EDTA cannot recover liver damage caused by lead toxicity.

Metal Flush recovers liver damage and does not inhibit
hemoglobin biosynthesis.

Lead Chelation: Metal Flush vs. EDTA
(3-week animal study)
Serum Metal Level (mol)
Group
Lead Zinc
Negative Control 0.85 19.73
Lead (Positive Control) 1.74 18.36
Lead + EDTA 0.97 14.84
Lead + Metal Flush 0.88 19.13
With Metal Flush, lead level is almost similar to negative

control group, better than EDTA group. Metal Flush does not
remove zinc. EDTA removes zinc.

Children with Lead Toxicity
Risk of ADHD
Loss of appetite
Hyperactivity
Irregular sleeping habits
Temper tantrums
Lack of concentration
Metal Flush chelates lead in children safely and

reduces/eliminates associated symptoms.
Metal Flush on Lead Toxicity
(68 children, ages 3-12)
0.3
2 weeks
0.2 0.24
g/mL
0.1
0.12
0.0
Day 0 Day 14
Zinc level increased from 4.58 to 4.87 g/ml

Associated symptoms reduced

CASE REPORT
J. Kaslow, MD from CA, says that he has tried

many different formulas for children with
ADHD but, only Metal Flush works. He
recommends giving a child a buffered Vitamin
C drink in the morning and Metal Flush in the
evening. From his experience, a month of
Metal Flush has reduced hyperactivity in
every child he has treated.

Metal Flush removes Mercury
0.7
0.556 50 cases
Mercury in urine (mol/L)
0.6
0.483
0.5 0.428
0.4
0.27
0.3 0.23
0.2
0.1
0
0 7 14 21 28 days
Normal mercury in urine is < 0.250 mol/L
Metal Flush does not remove essential trace elements and has no side effects

Advantages of Metal Flush
Easy administration Children (ages 3 and
Inexpensive above) can take
No side effects Kidney patients can
Does not strip take with Asparagus
essential elements Extract and use with
Bathdetox

Blue Veins under Tongue
Earlobe crease with Red / Black Spots
Heart (89%) Copyright. Chis Enterprise, Inc.
Has a high chance for bypass surgery.

Protocol: Vein Lite, OxyPower, Asparagus Extract and
Metal Flush

D. Dornfeld, DO from NJ, recommends
the following to patients:
Angina pectoris: Vein Lite and

OxyPower relieved chest pain
IV Chelation: Metal Flush, Asparagus
Extract and Vein Lite

Copyright.
Chis Enterprise, Inc.
The kidneys must be in good

condition prior to IV
chelation
Bubbles in urine or Edema
Bubbles in
the urine indicates a kidney problem
Copyright.
Chis Enterprise, Inc. Protocol for patients with
heavy metal toxicity and
kidney problems: Asparagus
Extract, Kidney Chi, Metal
Leg Edema
Flush, Bathdetox

Asparagus Extract
Induces diuresis
Reduces creatinine levels
Has the ability to chelate
mercury

CASE REPORT
A.B., 50 y/o/f from NV, had 20 EDTA and 20

DMPS IV chelations that made her feel nauseous
and very sick. After taking Metal Flush, Vein Lite
and Asparagus Extract for 5 months, her heavy
metal levels reduced.
Before After 5 months
Aluminum 140 59
Arsenic 92 50
Cadmium 2.4 1.7
Mercury 13 1.5
Nickel 61 7.5

CASE REPORT
G. Simonian, DC from CA, has an 80 y/o/f

patient with memory loss and dementia. A hair
analysis revealed that her aluminum level was
high. She took Vein Lite, Metal Flush and used
Bathdetox.
Hair analysis Initial After 3 months

14 <8
Aluminum (ppm)
High Normal

ANEMIA
KOILONYCHIA
Concave or
spoon-like
nails

CASE REPORT
C. Chrencik, DC from AL, has a

patient with anemia who took Chi-F
and Chi Energy for 3 months.
Initial After 3 months

Hematocrit 26 34
Hemoglobin 8 12

Chi-F Functions
Improves anemia and malnutrition
WBC, especially after
chemotherapy
RBC, Hemoglobin
Platelets (ITP) by 81%

Chi-F and Iron have comparable effects on
Bone Marrow Synthesis in Mice
40
35 38.07 38.26
30
30.6
% Change
25 27.89
20
20.4
15 16.67
10
Chi-F
Chi-F
Chi-F
Iron
Iron
Iron
5
0
Red Blood Cells Hemoglobin Erythropoietin
(x 1012/L) (g/L) (ng/mL)

Chi-F increased Platelets in
107 Patients (3 months)
90 79.44
80
70
Effective Rate (%)
60
50
40
30 20.56
20
10 0
0

Hormonal Imbalance
Red
spots Copyright. Chis Enterprise, Inc.

CHI-F
Hormone Balance, Menopause, PMS
Recommended for pre- and postmenopausal women as well as men
Balances estrogen, testosterone, progesterone

90% PMS PAIN
Irregular menstruation (75%)
Abnormal uterine bleeding (93%)
Menopausal Syndrome (NHRT)
Promotes fertility in both women and men
LD50 > 5g/kg

CHI-F 1 of 2
for Hormonal Balance
Angelica Astragalus
Immunity
Enriches
Lung
blood
Heart
Circulation
Improves
Regulate
chi
menstruation
Tumor/
Relieves pain
fibroid

CHI-F 2 of 2
for Hormonal Balance
Cyperus Salvia
Removes
Hormonal blood stasis
balance Promotes
Breast blood flow
conditions Angina
Uterine Heart
bleeding
Pain

Chi-F on 280 Women with
Dysmenorrhea (3 months)
50
48.21 Overall
40 Improvement
41.07 89%
Effective Rate (%)
30
20
10
10.71
0

Chi-F on 60 Women with PMS (3 months)
110
Overall Effectiveness:
96.67%
100
100
Effective Rate (%)
90 96.55
93.33
80
70
60
50
Heavy PMS Intermediate Light PMS
PMS

CASE REPORT
D. Hoover, DC from IA, had a 15 y/o/f

patient who suffered from cramps and
other PMS symptoms. After using Chi-F
for 3 weeks, her symptoms disappeared.
Two years later, she reports that she never
experienced any problems with PMS.

CASE REPORT
J. Weber, DC, DCBCN, from NY,

has a 19 y/o/f patient who didnt
have a period for 1 years. After
taking Chi-F and Vein Lite for 5
weeks, her period resumed. Now she
has regular periods.

CASE REPORT
J. Staniland, MD from TX, has a

16 y/o/f patient with a painful
ovarian cyst. After 3 weeks on
Myomin and Chi-F, her pain was
completely alleviated. After 3
months, her cyst and pain cleared.

In men and women
Fibrocystic Breast, Ovarian Cysts,
Endometriosis, Uterine Fibroids, Prostate,
BPH, Testicles, Liver/Kidney/Thyroid Cysts
Insulin Resistance
Belly Fat

DIABETES HORMONES
WEIGHT CANCER
MANAGEMENT ESTROGEN
SEXUAL AUTOIMMUNE
VITALITY CARDIOVASCULAR DISEASE
HEALTH

Physical Markers of
Estrogen Dominance
Red dots on the tongue
Cherry angiomas on the abdomen
White spots on the nail
Facial hyperpigmentation

Hormonal Imbalance
White
spots

Cherry angiomas

Cherry Angiomas on Abdomen
If > 10 to 15 large ones
Men: Prostate Cancer risk
Women: Breast Cancer risk
Or Liver Cirrhosis in both men
and women
159
Facial Hyperpigmentation:
Estrogen dominance
Chloasma, Melasma
MYOMIN
for Estrogen-Dominant Conditions
Curcuma Cyperus Astragalus

Hormonal Immunity
Tumors in the
reproductive balance Lung
organs Breast Heart
(uterus, conditions Improves
prostate) Uterine chi
bleeding Tumor/
fibroid

MYOMIN
Aromatase reducer for women and men
( Estradiol, Estrone, Testosterone)
Competes with estradiol at estrogen
receptors
Belly Fat
Also for Type II Diabetes patients (with
Diabend and OxyPower

MYOMIN MECHANISM
Aldosterone
Corticosterone 11- Cortisol Cortisone

Deoxycortisol
Aromatase 2-OH
estrone
Estrone
Proges- 17-OH 16-OH
terone Progesterone estrone
MYOMIN
MYOMIN/
DIM
17-OH Androste- Testos-
Pregnenolone Pregne- DHEA Estradiol
nedione terone
nolone
5- reductase Aromatase
DHT
Cholesterol
16-OH
16-OH
dehydroepi-
androsterone
Estriol
androsterone

Myomin reduces Estradiol
Postmenopausal Women with Fibroids/Cysts
80
60 patients
60 74.52
40
38.84
20
0
Before 10 Days After
Postmenopausal women: Estradiol level < 30 pg/ml
164
CASE REPORT
F. Cromeyer, RPh from TX, has a female patient

in her 50s who took Myomin for 2 months. Her
estradiol level reduced from 6.5 to 2.4 pg/ml.
Saliva Premenopausal
Before Myomin After 2 months
Test range
Estradiol 6.5 HIGH 2.4 NORMAL 1.0 3.2 pg/ml

CASE REPORT
J. Carrozzella, MD from FL, has a male

patient in his 50s who took Myomin. After
only 3 weeks, his estradiol level reduced from
60 to 25 pg/ml.
Serum
Before Myomin After 3 weeks Male range
Test
Estradiol 60 HIGH 25 NORMAL 6 30 pg/ml

Myomin, Aromatase Reducer
Recommended for pre- and
postmenopausal women
Recommended for men
Multiple applications for estrogen-
dominant and hyperaromatization
conditions

Myomin Plus
Modified version of Myomin
Same aromatase reducer function as Myomin
but with less gastrointestinal side effects
Core ingredients of Myomin (Curcuma,
Cyperus) kept, ingredients added to counteract
gastrointestinal side effects
Recommended for those who experience
bloating, upset stomach, etc. when taking
Myomin (~2% of people taking Myomin)

Myomin reduces DNA expression of aromatase in
both ovarian and endometrial tissue in rats
Ectopic
endometrium
tissue
Ovarian
tissue
Negative Control Positive Control Myomin after 28 days

No stains Tremendous aromatase Aromatase expression
expression inhibited

Comparison of grayscale values of
aromatase expression in rat endometrial
and ovarian tissues
Ectopic
Ovary
Group endometrium
(mean + SD)
(mean + SD)
Negative control 48.0 + 8.5 29.7 + 6.4

Positive control 108.9 + 29.03 149.8 + 33.86
Myomin group
34.7 + 5.2 47.0 + 9.19
(28 days)
Aromatase reduction
100% 85.6%
(Myomin)

AROMATASE INHIBITORS
Product Manufacturer
Indication
Administration, Cost Approval Date
ARIMIDEX AstraZeneca Breast cancer in
Oral, 12/27/1995 postmenopausal women
$380/month
AROMASIN Pharmacia Advanced breast cancer in
Oral, 10/21/1999 postmenopausal women
$377/month after tamoxifen therapy
FEMARA Novartis Advanced or metastatic
Oral, 1/10/2001 breast cancer in
$442/month postmenopausal women

AROMATASE REDUCER
Product
Type Indication
Administration, Cost
MYOMIN Dietary Estrogen-related conditions
Oral, $45- Supplement (cysts, fibroids,
$90/month ovarian/breast/ prostate
No side effects cancer, etc) in men and
women.

Myomin on 255 Patients with
Ovarian Cysts and Endometriosis
60
50
57.6 ~ 5 months
40
% 30 34.1
20
10
8.2
0
Effective Improvement No Change
1994 study from Chang Hai Hospital in Shanghai, China

Overall Improvement Rate of 92% within a 5-month period.

CASE REPORT
J. Wright, MD from WA, has a 62 y/o/f

patient who had a 2cm ovarian cyst in
2006. Two years with conventional
treatment had no effect. After Dr.
Wright gave her Myomin for 2 to 3
months, the ovarian cyst quickly
cleared.

CASE REPORT
"The Myomin has proven

exceptional in reducing hard to
dissolve fibroid tumors and liver
and kidney cysts.
- M. McCain, ND from AR

Myomin + Revivin + Angiostop
on 60 patients with Uterine Fibroids
70
60 69.2 6 months
50
40
%
30
20
10 19.0
11.8
0
Effective Improved No Change
*Those with uterine fibroids over 5cm should add
Revivin and Angiostop for better results.

CASE REPORT
I. Mena, DO from CA, has a 40 y/o/f

patient with multiple fibroids (one is
3.5 cm in diameter). After 4-5
months on Myomin, an ultrasound
revealed that the fibroids have
completely cleared.

Myomin on 100 Patients with
Fibrocystic Breasts
60
50 60 6 months
40
30
%
20
30
10
10
0
Effective Improved No Change
90% improved in 6 months
94% of the pain associated with cystic fibrosis had disappeared

CASE REPORT
J. Blair, ND from NJ, has a 48 y/o/f patient who

has had dense breasts. She always needed an
ultrasound to check her breasts for lumps. After
1 years on Myomin, this is the first time in her
life that a mammogram shows a clear picture, no
more denseness at all. Her breast pain was also
eliminated and her period has become regular.

CASE REPORT
A 56 y/o/f from Florida has cherry angiomas on her abdomen and

all over her body. She relates that she had a lump in the left
breast, so she took Myomin and Angiostop for about 4 months.
Seen through thermographic breast imaging, angiogenesis around
the area has evidently reduced and the lump has cleared.
2/28/10 7/12/10

CASE REPORT
Y. Dikansky, ND from NY, has a 48 y/o/f

postmenopausal patient who had breast cancer at
age 38 and age 43. In May 2011, at 48 years old, she
found that she had fibrocystic breasts and high
estradiol and started taking Myomin. Two months
later, a biopsy revealed that it was not cancerous.
Premenopausal
Urine Test May 2011 Oct 2011
range
Estradiol 196.50 HIGH 53.21 NORMAL 5.0-54.7 pg/ml

CASE REPORT
M. Guevara, MD from CA, has a 49 y/o/f patient

with Stage 3 estrogen + breast cancer. She had a
bilateral mastectomy in October 2013. In December
2013, her estradiol level was high at 278. So she
started Myomin in February 2014. After 3-4 months,
her estradiol reduced to normal.
Dec 2013 June 2014 Reference

Estradiol 278 22 < 31 pg/ml
Feb 2014 - Started Myomin

Oct 2013 - Double Mastectomy

Factors of Estrogen Dominance
I. Long-term Elevated Hormones Levels
Among women with fibrocystic breasts for
over 20 years, 17% developed breast cancer
II. Obesity/Belly Fat
III. Xenoestrogens
IV. Hyperaromatization

I. Long-term Hormone Stimulation
Breast Abnormalities
40% women of childbearing age already develop
fibrocystic breasts
42%: First time breast cancer diagnosis at 65 years old
1 in 6 American women who reach 80 years old
develop breast cancer
Women over 70: >70% breast cancer cases are
hormonal (normal breast tissue and fat cells contain
aromatase local estrogen production)
*Source: W Myeroff. Women over age 70 DO get breast cancer. Erickson Tribune.

Dense Breast Tissue: Risk for Breast Cancer
More than half of all women have dense
breast tissue
Risk for breast cancer is 5x greater in
women with dense breast tissue
Senate Bill 791 (CA) effective 4/1/2012
Requires that patients be informed of their
breast cancer risk if dense breast tissue is
found in mammogram

Breast Calcification: Precancer
Small clusters of breast calcification is an

early warning sign of breast cancer
Should be treated immediately
Sources: Int J Bioinform Res Appl. 2010;6(4):418-34.

Br J Cancer. 2010 Sep 28;103(7):1034-1039.

II. Obesity
Obese persons: estradiol, testosterone levels
Postmenopausal obese women

Estrogen level is 50 to 100 times higher
Risk for breast cancer, etc.
Fat tissue has aromatase concentration
Leads to more estrogen production
Source: National Cancer Institute

CASE REPORTS
M. Steward, DC, has a 49 y/o/m patient who

took Myomin and lost 25 lbs (mostly belly fat)
in less than 3 months.
E. Saugen, DC from MN, has a 48 y/o/m
patient who lost 25 lbs and 3 inches around the
waist on Myomin.
L. Fickes, DC from HI, has a 54 y/o/m patient
who lost 18 lbs and 4 inches around the belly
after 6 months on Myomin and Slender All.

Myomin for Belly Fat
Aromatase converts testosterone into
estrogen. More estrogen means more fat
accumulation, especially in the belly, which
has the highest amount of aromatase.
Myomin inhibits aromatase and consequently
reduces belly fat.
For weight loss, take Myomin with
Slender All and ProMetabolic.

S.L., a 29 y/o/f from NY, weighed 190 lbs when she
started Myomin, Slender All, Pro-Metabolic. After 2
years, she has lost 65 lbs.
190
Weight loss after
only 4 months on
Myomin, Slender
All and Pro-
Metabolic
BEFORE AFTER

III. Xenoestrogens
(Environmental Hormones)
Substances that mimic the effects of
estrogen
Attach to estrogen receptors and disrupt
endocrine functions
Common xenoestrogens: clouding agents,
pesticides, phthalates in plastics, dyes

Plasticizers: Xenoestrogens
DEHP, DINP, BBP, DBP
Plasticizers as clouding agents
found in sports drinks, juices,
tea drinks, fruit jams or syrups,
and tablets or powders
Causes cancer and damage to the reproductive
system, heart, kidneys and liver
Men: Has feminizing qualities, reduces sperm
Women: Early puberty, breast cancer risk

Myomin counteracts the effects of
xenoestrogens by competing with
estrogen and binding to estrogen
receptors
Hugo Rodier, MD, from Utah

recommends MYOMIN for his patients
who are exposed to xenoestrogens

IV. Hyperaromatization of Testosterone
Pregnenolone Cholesterol
Aromatase
Estrone (E1)
Progesterone
MYOMIN
DHEA Androste- Testosterone Estradiol (E2)

nedione
Aromatase
Estriol (E3)

HRT, BHRT Cancer Risk
HRT users (Prempro, Premarin, DHEA,
Progesterone, testosterone, estradiol, etc. and
even birth control pills)
63% higher incidence of breast,
ovarian and endometrial cancer
combined compared to non users
Sources: Lancet. 2007 Apr 10; JAMA. Nov 2009.
Bioidentical Hormone Replacement Therapy (BHRT) users also

have issues due to hyperaromatization of testosterone to estradiol

HRT Increases Breast Cancer Risk
England Study: If Estrogen + Progesterone are used
together
66% increase in breast cancer incidence
~15,000 more cases per year
If only progesterone is used
22% increase in breast cancer incidence
Total of 20,000 more breast cancer cases every year
Source: Family Physician. Sep 2003.

Progesterone
Listed as Carcinogenic under Californias
Prop 65 since 1988
A listed substance may be natural, synthetic or
even naturally produced in the body
Progesterone products should have a warning
label
Source: NNFA Today. Sep 2004; 18(9)
Even bio-identical hormones may pose a risk

Any type of Hormone Therapy
Increases Breast Cancer Risk
Estrogen + Progesterone Study

Years of use Risk
10 15 88% higher than non-users
15 20 Double than those using for 10-15 years
Risk keeps increasing with longer durations of

use and never tapers off
Source: American Association for Cancer Research. April 1, 2012.

Hyperaromatization Case
J. Wright, MD from WA, has a male patient on daily
75mg testosterone therapy, which caused an increase in
estradiol. Within 2 months of taking Myomin, his
abnormal estradiol level was within normal range.
Test Before After Reference

Estradiol 50.4 13.3 6-30 (pg/mL)
Testosterone 645 639 300-750 (ng/dL)
Testosterone/
12.8 48.0 20-50
Estradiol Ratio
200
Hyperaromatization
Coexisting Conditions Symptoms
Insulin Resistance Overweight
Cholesterol Low libido
Hypertension Lose muscle tone
Triglyceride Gynecomastia
Source: Jonathan Wright, MD. Bio-Identical Hormone Replacement Therapy:

Common Issues and Solutions. Townsend Letter. Jan 2010.

CASE REPORT
V. Jefferson, DC from NY, has a 58 y/o/f patient on

bio-identical estrogen and progesterone. She has a
myoma the size of a 7-month fetus and heavy
bleeding. Shes already had a 6-pint blood
transfusion but was frustrated because she was still
bleeding. She was so thrilled because only a day
after she took Angiostop, Myomin and Revivin,
her bleeding stopped. Since then, her symptoms
improved. A year later, her myoma is much
smaller, and she had no more bleeding.

Hormone Replacement Therapy,
including Bio-identical hormones,
and birth control pills, leads to
Hyperaromatization of testosterone
Add Myomin to avoid hormone-
related side effects
203
CASE REPORT
G. Depke, ND from CA, has a 47 y/o/f patient

taking progesterone and DHEA for adrenal fatigue.
She had high E2 and Progesterone levels and low
Pg/E2 ratio. She took Myomin for 4 months.
Premenopausal
Serum Test Sep 2012 Jan 2013
range
Estradiol (E2) 10.4 1.6 1.5 10.8 pg/ml
Progesterone 523.0 387.9 127 446 pg/ml
Pg/E2 ratio 50.29 242.44 200-600

Suzanne Somers Interview with
Dr. Jonathan Wright
In any situation, make sure
E3 > E1 + E2
Women were more likely to be long-term breast
cancer survivors...if they had more estriol (E3)
than estrone (E1) and estradiol (E2)
Source: Townsend Letter. Aug/Sep 2010: 54-56.

CASE REPORT
BHRT without Myomin: EQ not normal

R.B., 59 y/o/f from IL, has been taking
progesterone for hormonal imbalance but did not
take Myomin. About a year later, her hormones
are still imbalanced. Her Pg/E2 ratio is 30
(should be over 200). And her EQ is under 1.
E1 E2 E3 EQ = E3/(E1 + E2)
3.7 0.5 1.7 0.41
Progesterone 111
Pg/E2 ratio 30

CASE REPORT
BHRT with Myomin: EQ excellent

M. Renaud, LAc from FL, has a 52 y/o/f
patient who has been on BHRT but still had
hormonal imbalance. Then she added
Myomin for 8 months.
E1 E2 E3 EQ = E3/(E1 + E2)
11.2 6.7 36.1 2.02

CASE REPORT
I. Ekasari, PhD from CO, has a 59 y/o/f patient with

breast and thyroid nodules. After 1 years on
Myomin, Angiostop and Revivin, her E1, E2 and E3
levels are within normal range. Her EQ is over 1.0,
signifying a lower risk for breast cancer. Her breast
and thyroid nodules have also reduced
E1 E2 E3
17.46 1.08 18.97
EQ = E3/(E1+E2) 1.02

CASE REPORT
L. Whitson, MD from CA, has a 46 y/o/f patient with

right ovarian cyst. She was given Myomin in 2013.
Her EQ increased from 0.78 to 2.21 in one year.
EQ = E3/(E1+E2) > 1 Started Myomin
Saliva
12/21/07 02/07/09 12/01/10 12/16/12 12/27/13 Reference
test
Age 40 42 43 45 46
E1 3.5 2.6 4.7 6.6 3.2 5.8 34.2
E2 1.0 1.1 0.9 1.6 1.0 1.0 3.2
E3 9.0 6.8 8.5 6.4 9.3 < 30
EQ 2.0 1.84 1.60 0.78 2.21 > 1.0

CASE REPORT
P. Tunbridge, MD from Australia,

reports that he has monitored a female
patient whose condition has improved
using Myomin instead of DIM.
I3C and DIM targets estrogen
metabolites too late in the pathway. It is
much better to reduce estrogen earlier in
the process using Myomin.
CASE REPORT
Aromatase
2-OH estrone
Estrone (E1)
16-OH estrone
MYOMIN
Androste- Testos
Estradiol (E2) MYOMIN/
nedione terone
DIM/I3C
Aromatase
Estriol (E3)
L. Lauterbach, DC from CA, has a 65 y/o/f patient who had high

16-OH at 622 pg/mL. Instead of DIM and I3C she took Myomin.
After 6 months, her 16-OH reduced. Her EQ increased to normal.
Feb 2014 Aug 2014 Reference range

16-OH 622 360 213-680 pg/mL
Aug 2014 E1 = 33 E2 = 26 E3 = 80 EQ = 1.36

HRT, BHRT Ovarian Cancer Risk
Risk of Ovarian Cancer

44% increased risk with HRT use
13% increased risk with estrogen patch
23% increased risk with intravaginal estrogen
23% more likely to die of ovarian cancer
Sources: Lancet. 2007 Apr 10; JAMA. 2009; 302(3):298-305.

Recommend Myomin in these Cases
Case 1 Case 2 Case 3

Patient has Patient on Patient has
hormone imbalance BHRT estrogen-dominant
but does not want condition
BHRT
No BHRT, only
Give Myomin Add Myomin
Myomin

Estrogen
and the
Prostate
Red Dots on the Tongue: Prostate Problems

Cherry Angiomas on Abdomen: Prostate Problems

PROSTA CHI
Benign Prostatic
Hyperplasia (BPH)
Prostatitis
Hair Loss in men
Add Myomin for best effects for men
217
PROSTA CHI 1 of 2
for Prostate Conditions
Melia Citrus
Digestive
Prostate
Hemorrhoids
Testicles
Invigorate
Infection
spleen
function

PROSTA CHI 2 of 2
for Prostate Conditions
Phellodendron Salvia
Removes
UTI blood stasis
Infection Promotes
blood flow
Prostatitis
Angina
Heart
Pain

Prosta Chi on BPH
90 78.45
80 (519)
738 cases
70
60
50
% 40
30 17.89
20 (132)
10 2.66
(27)
0

Prosta Chi on Prostatitis
90 78.25
80 (295) 377 cases
70
60
% 50
40
30
14.85
20
(56) 6.90
10 (26)
0

Prostate Protocols
Condition Protocol
Prostatitis caused by
Prosta Chi, Kidney Chi
infection
Sexual problems with

Prosta Chi, SXD, Super X
prostate symptoms
Prostate problems + Angiostop, Myomin,

high PSA level Prosta Chi, Revivin

CASE REPORT
V.C., a 44 y/o/m had prostatitis. He

experienced a burning sensation in the perineal
area and pain in the abdomen. His sexual
function has also reduced. He took Cipro and
other antibiotics for a year with no apparent
effect. After taking Prosta Chi and Kidney Chi
for 3 months, all his symptoms cleared and his
sexual function returned back to normal.
223
MYOMIN Functions for Men
Inhibits the aromatase enzyme
Estrogen
Testosterone level
PSA level
Myomin + Prosta Chi for Men

CASE REPORT
Testosterone Use with Myomin

G. Adams, MD from FL, has a male
patient on testosterone therapy who took
Myomin for 5 months. His estradiol
reduced to a normal 25 pg/ml.
After 5
Serum Test Before Myomin Male range
months
95 25
Estradiol 6 30 pg/ml
High Normal

CASE REPORT
G. Depke, ND from CA, has a 52 y/o/m patient

whose E1 and E2 levels were high. After 4
months on Myomin, both his E1 and E2 levels
reduced to within normal range.
Before
Saliva Test After 4 months Male range
Myomin
Estrone (E1) 3.6 2.6 0.5 3 pg/ml
Estradiol (E2) 11.7 2.5 1 3 pg/ml

CASE REPORT
B. Sanborn, DC from MI, has a 16 y/o/m patient

with gynecomastia. He has tried 8 different
supplements, including DIM and indole-3-carbinol
(I3C); however, they had no effect on his estradiol or
DHT. After taking Myomin and Prosta Chi for two
months, his estradiol and DHT levels reduced. His
gynecomastia also improved.
Serum test Before After 2 months

Estradiol 300 70
DHT 1,100 250

PSA and Prostate Cancer
A PSA level of 2 was considered as prostate cancer.
Then in 1995, the PSA threshold was raised to 4.
Age Ideal PSA

40s < 0.1
50s < 0.5
60s < 1.0
PSA should not exceed 2
PSA of 2-4 means precancer of the prostate
Nov. 2002 Ronald Wheeler, MD,
reported at the ACAM meeting in
Orlando, FL, that if men in their 40s have
PSA >0.7 (49 years and younger), they
may already have prostate cancer
At the Annual Cancer Convention on

Sept. 1, 2003 in CA, Dr. Wheeler
reiterated that prostatitis causes prostate
cancer when PSA level exceeds 1

PSA Test Predicts Prostate
Cancer Mortality
Prostate cancer mortality was highest among
these age groups after 30-year follow up:
Age 45 49 with PSA > 1.6
Metastatic prostate cancer risk cannot be ruled
out if
Source: British Medical Journal. Apr 15, 2013;346

CASE REPORT
R. Welch, DC from CA, has a 76 y/o/m patient with

PSA level of 3.82. He has been taking Terazosine and
Finasteride* daily.
Test Date PSA Level

3/22/2011 3.82
5/26/2011 3.49
12/08/2011 1.79
9/6/2012 1.05
*Finasteride has been linked to increased malignancy when

taken by men who already have prostate cancer.

Prosta Chi and Myomin for
Prostate Problems
Pregnenolone Cholesterol
Benign Aromatase
Estrone
Prostatic Progesterone
Hyperplasia DHEA
Androste- Testos-
Estradiol
nedione terone
(BPH) 5-
Aromatase
reductase
Prostatitis DHT
Hair Loss in Estriol

men Myomin Prosta Chi

CASE REPORT
H. Lee, DMD from CA, has a 35 y/o/m

patient who used finasteride (Propecia) for
hair loss. Within 1 years, his hair grew
but he developed breast lumps. A
mammogram found some inflammation in
his breast. His doctor suggested surgery.
He stopped finasteride and started on
Myomin.

CASE REPORT
C.D., 45 y/o/m from FL, has been taking the

following:
DHEA (10mg/day) Doxazosin (BPH drug)
Tribulus (338mg QID) DIM (100mg/day)
Stinging nettle root (300 mg BID)
Zinc (55 mg/day)
His PSA level increased from 1.3 in February
2009 to 1.8 in November 2010. His
testosterone is low at 293.

CASE REPORT
Testosterone Use without Myomin

J. Wycoff, DO from MI, has a 65 y/o/m
patient given 150 mg daily testosterone
for 3 months.
Serum Test Initial After 3 months
PSA 2.85 4.2
E2 25 35

CASE REPORT
Testosterone Use without Myomin

J. Young, MD and M. Perkins, DOM, AP from FL,
have a 55 y/o/m patient who had weekly
testosterone shots. He was also taking Arimidex.
His PSA, testosterone and Gleason score increased.
He had to undergo prostate cancer surgery.
Serum Test Before After
Testosterone 250 800
PSA 3.25 7.2
Gleason Score -- 7

CASE REPORT
V.H., 60 y/o/m from CA, had elevated PSA and low

testosterone levels in 2010. He also suffered from
low libido. He took Myomin and Prosta Chi for 6
months and both his PSA and testosterone levels
normalized.
Test 2007 2010 2011 Reference
3.0 1.4
PSA 1.5
High Normal
< 2.0
256 428
Testosterone 256
Low Normal
300-750 ng/dl
Free 229 386

229 250-1100 ng/dl
testosterone Low Normal

CASE REPORT
D. Caron, DC from SD, has a 52 y/o/m

patient whose testosterone level
increased to 460 ng/dL after 6 months
on Myomin.
Before After 6
Test Male range
Myomin months
Testosterone 280 460 300-750 ng/dL

Estrogen causes Prostate Cancer
While there are conflicting reports about estrogens role
in prostate cancer, more studies are emerging that shows
a strong link between them.
Int J Cancer. 2006; 118(9):2123-31
Ann NY Academy of Sciences. 2006; 1089:77-193
Minerva Endocrinol. 2006; 31(1):1-12
J Cell Biochem. 2007; 102(4):899-911
Reprod Toxicol. 2007; 23(3): 374-82
FASEB J. 2007 Nov 30 [Epub].
Basic Clin Pharmacol Toxicol. 2008 Feb; 102(2):134-8

CASE REPORT
S. Downs, MD from CA, has an 80 y/o/m with prostate cancer.

After treatment, he took dutasteride (Avodart) and his estradiol
and PSA still high. Then he added Myomin and Prosta Chi.
PSA
Date Estradiol Notes
level
9/2011 60 5.0 Avodart only
11/2011 39 2.88 After 2 months, Myomin + Prosta Chi
He stopped Myomin and Prosta Chi,
01/2012 59 5.6 his levels increased. So he started
taking them again.
04/2012 31 3.6 After 3 months on Myomin, Prosta Chi

Prostate Enlargement and Infection,
PSA high
R. Ornelas, DC from CA, has a 54 y/o/m
patient whose testosterone level increased
and PSA reduced after a year on Myomin,
Angiostop, Prosta Chi and Kidney Chi.
Test Before After 1 year Male range

Testosterone 200 540 300-750 ng/dl
PSA 8.7 2.4 < 4.0

Testosterone Therapy (TT) Increases
Cardiovascular Risks
Study on 55,593 men on TT for 90 days*
CVD history Age Increased Risk of
Heart Attack
With CVD history < 65 2-3 times
> 65 2 times
> 75 3 times
No CVD history > 65 2 times
Study on 8,709 men with low T and on TT for 3 years**

29% increased risk for stroke, heart attack or death
with or without history or coronary artery disease

MYOMIN FUNCTIONS
Fibrocystic breast Colon polyps
Endometriosis Cervical cancer
Ovarian cyst/PCOS Breast cancer
Uterine fibroid Ovarian cancer
Thyroid cyst Uterine cancer
Kidney cyst Prostate cancer
Liver cyst Testicle cancer
Neurofibromatosis Lung cancer
Type II Diabetes Reduces belly fat
Acne Competes with xenoestrogens,
reducing their effects
243
CASE REPORT
S. Young, ND from CO, has a 38 y/o/f

patient with a colloid cyst on her
thyroid. MD was giving RX to shut
down her thyroid and see what would
happen. She tried Myomin instead
and the cyst melted away in 3 weeks.

CASE REPORT
J. Weber, DC, DCBCN, from NY, has a 33 y/o/f

patient with PCOS. After a month on Myomin and
progesterone, her periods became regular. A year
later, her hormones are balanced.
10/3/2011 Premenopausal
Saliva Test 9/15/2010
(Pg + Myomin) range
Estradiol (E2) 2.2 1.76 1.0-10.8 pg/ml
Progesterone (Pg) < 10.0 219.26 127-446 pg/ml
Pg/E2 ratio 4.40 124.58 200-600
Testosterone 55.10 43.09 5.9-49 pg/ml

Estrogen related to
Diabetes and
Insulin Resistance
Diabend, OxyPower, Myomin

Hypoglycemia
Teeth marks

Insulin Resistance, Diabetes, PCOS
Dark, wrinkly
pigmentation
Acanthosis nigricans
Children: Fatty liver
Skin tags
80% Type 2 Diabetes risk
May also be a colon problem
50% chance colon polyps

Diabetes and Insulin Resistance Linked to
Estrogen Dominance
Among 99 patients with endometrial cancer (estrogen-

responsive), 30 had diabetes*
Exposure to environmental hormones caused insulin
resistance and altered pancreatic beta cell function
Insulin resistance present in at least 1 in 3 men with
below-median serum testosterone (hyperaromatization)
Check for insulin resistance if low or below-median
testosterone (Dr. Jonathan Wright, MD)
*Sources: Amer J Obstetrics & Gynecology. 2011; 204(4):355.

Nat Rev Endocrin. 2011 Apr 5 epub.

Protocol for Type II Diabetes
Diabend
Myomin
Reduces hyperaromatization that can lead to
insulin resistance
OxyPower
Reduces HbA1c
Repairs peripheral vascular damage to prevent
neuropathy

DIABEND 1 of 2
for Insulin Resistance, Diabetes
Gymnema Morus alba
Lung
Diabetes
Vision
Pancreas
Diabetes
Nourishes
yin and blood

DIABEND 2 of 2
for Insulin Resistance, Diabetes
Astragalus Coptis
Pancreas
Immunity
Stomach
Lung
Liver
Heart
Gallbladder
Improves
chi Diabetes
Pancreas
Main component is berberine

Berberine on 116 Type 2 Diabetes Patients
Berberine extract from Coptis
Average Result Day 0 Day 90
Fasting Blood Glucose 126 101

2-hour Post-Prandial Glucose 216 160
HbA1c 7.5% 6.6%
Triglycerides 221 141
Total Cholesterol 205 168
LDL cholesterol 125 97
Source: Zhang Y et al. J Clin Endocrinol Metab. 2008; 93(7): 2559-65.

DIABEND for
Type II Diabetes (6 months)
Effective
Group Total Cases Effective Rate
Cases
Diabend 195 133 68.2%
Control 30 2 7.0%
Main ingredients: Astragalus, Gymnema, Momardica, Coptis

Diabend Functions
Blood glucose
LD50 > 10g/kg
Glucose tolerance
Insulin receptor sensitivity
Beta cells of pancreas to produce more
insulin
Antioxidant
Regulates lipoprotein metabolism by FGF21

Diabend Reduces FGF21
Fibroblast growth factor 21 (FGF21)
Master regulator of the metabolic profile
Controls both glucose and lipid metabolism
Reducing FGF21 in liver and blood can
regulate glucose and insulin levels
Source: Scientific Reports. 2013;3:3142.

Hemoglobin A1c (HbA1c)
Predictive biomarker for sugar, energy,
diabetic/ insulin resistance risk, metabolic
syndrome
HbA1c linked to inflammation and chronic,
degenerative and autoimmune disease risks.
Source: Townsend Letter. Jan 2014: 91-101

CASE REPORT
L.H., 65 y/o/f from NY, is a diabetic and had a

fasting HbA1c level of 7.6. After 6 months on
Myomin, Diabend and OxyPower, her HbA1c
level reduced to 6.5.
After 6 Reference
Serum Test Before
months range
HbA1c 7.6 6.5 < 5.7
Studies show that every 1% drop of the Hb1Ac also

reduces the risk for CHD by 18%

CASE REPORT
A 69 y/o/f from NY had a slightly elevated

HbA1c level. After taking Diabend, OxyPower,
and Myomin for 5 months, her HbA1c level
reduced by 5%.
Date HbA1c level
She started
Oct 2009 5.9
using Diabend, Oct 2010 6.0
OxyPower,
Myomin Mar 2011 5.7

DIABETES HORMONES
Diabend/ Myomin 1
OxyPower Prosta Chi

WEIGHT CANCER
MANAGEMENT MYOMIN Angiostop 4
Slender All
Pro-Metabolic

SEXUAL AUTOIMMUNE
VITALITY CARDIOVASCULAR DISEASE
Super-X 5 HEALTH
OxyPower 2
Vein Lite 3
Asparagus Extract
Metal Flush

Dangers of Excess Estrogen in
Aging Males
Double the stroke risk
Heart Attack, Myocardial infarction risk
Atherosclerosis chance
Thrombus (blood clot) incidence
Prostate cancer, BPH risk
Sources:
Int J Cancer. 2006; 118(9):2123-31 Reprod Toxicol. 2007; 23(3): 374-82
Ann NY Acad Sci. 2006; 1089: 77-193 FASEB J. 2007 Nov 30 [Epub].
Minerva Endocrinol. 2006; 31(1):1-12 Basic Clin Pharmacol Toxicol. 2008 Feb;
J Cell Biochem. 2007; 102(4):899-911 102(2):134-8

Estrogen-Related Autoimmune
Disorders
Women are more likely than men to develop
estrogen-related autoimmune diseases
Condition Women to men ratio

Lupus 97:3
Thyroid problem 8:1
Gallbladder attack 6:1
Rheumatoid Arthritis 3:1
Sources: Nat Immunol. 2001; 2:777. Rheum. Dis. Clin. North Am.. 1994; 20:87.
J. Reprod. Med.. 1998; 43:335. Townsend Letter. May 2003: 64.
Engl. J. Med. 1998; 339:285.


SUPER-X
Not a vasodilator, No side effects
Adjusts the Hypothalamus-Pituitary-Adrenal
axis for sexual organ function
Slow-release: Starts working 4-8 hours after
taking it
Effect can last up for 2-3 days
Directions: Take 2 capsules daily for 2 days
2 capsules every 2 days
2 capsules per week

SUPER X
for Mens vitality
Panax ginseng Epimedium Wild Cordyceps

Only grows in high
Anti-fatigue Kidneys mountains, 4000m high
Heart Reproductive Hormones
Digestion organ vitality Aphrodisiac
Seminal Seminal
emission emissions
Kidneys
Lungs
Immunity

CASE REPORT
A. Bunzel, MD from CA, has a

70 y/o/m patient who could not
have an ejaculation for 3 years.
Super-X helped him achieve
orgasm and enjoyment.

OxyPower + Super X
+ Myomin + SXD for
Sexual Vitality
G. Mitchell, MD from VA, reports that
OxyPower enhances the effects of Super-X
for male vitality.

CANCER
Only thumbs have
lunulae (80%)
Physical signs
Especially if 8 lunulae were present

and then disappear feel cold
CASE REPORT
R. Shemesh, MD from FL, had a patient

with melanoma 10 years ago. He had no
lunulae at all and used Vein Lite and
Asparagus Extract. Now three lunulae
have reappeared on one hand while two
reappeared on the other hand.

Physical Signs to Determine Early
Signs of Cancer
TYPE OF
SYMPTOMS
CANCER
Frenula Cyst
(Colon/Intestine)
Frenula cyst
Colorectal
Shape of stool changes, sometimes with blood
Cancer
Soft, light-colored hair on the cheeks on adults
If the digestive symptoms suddenly change
Stomach
with severe pain
Cancer
Stomach bleeding
Esophageal GERD patients who feel like food is stuck in the
Cancer throat or it goes down very slowly

Stomach Esophagus/Stomach
2 1

Lump, thickening or wrinkle
Hard lump about 2 inches on the auricle
above or to the left of the navel

Soft baby hair on cheeks in adults
Colon or Lung Cancer

Signs of Cancer
TYPE OF
SYMPTOMS
CANCER
Breast and Red dots on tongue

Prostate Lots of cherry angiomas (>10 to 15) on
Cancer chest, may also be Liver Cancer
Cervical
Vaginal bleeding after intercourse
Cancer
Ovarian/
Sudden vaginal bleeding in postmenopausal
Uterine
women
Cancer

Signs of Cancer
TYPE OF CANCER SYMPTOMS
Kidney Cancer Urinary bleeding with no pain

Nail clubbing or opaque with chronic
Lung Cancer dry cough
Soft, light-colored hair on the cheeks
Lymphoma, Triangular nails
Leukemia Nail clubbing
Ear ringing on one side only (For brain
Nasopharyngeal,
cancer: also headaches and blurred
Brain Cancer
vision)

RTK Inhibitors: Targeted Therapy
Tyrosine Kinase Receptor (RTK) inhibitors/
Targeted Drugs or Smart Drugs
Block target cancer cells DNA expression of
proteins that specifically promote cancer growth
Do not harm normal cells, less toxicity
1998: 1st RTK inhibitor drug, Herceptin (EGFR
inhibitor), was approved for HER2+ breast cancer

Epidermal Growth Factor
The Wall Street Journal Europe 2002

Cell
Wall
Epidermal
Growth
Factor EGFR
Receptor Tyrosine
(EGFR) Kinase
(EGFR-
TK)
METASTASIS
(spreading to INVASION
other areas of (spreading into
the body) surrounding tissue)
ANGIOGENESIS INHIBITION OF
(formation of new blood vessels) APOPTOSIS
PROLIFERATION (preventing the cell from dying)
(tumor increasing in size)

1998 2014: FDA approval of RTK
and angiogenesis inhibitor drugs:
Herceptin (1998) Sutent (2006) Bosulif (2012)
Iressa (2003)* Sprycel (2006) Stivarga (2012)
Gleevec (2002) Tykerb (2007) Gilotrif (2013)
Avastin (2004) Afinitor (2009) Tafinlar (2013)
Erbitux (2004) Votrient (2009) Mekinist (2013)
Tarceva (2004) Caprelsa (2011) Cyramza (2014)
Nexavar (2005) Zactima (2011) Zykadia (2014)
Vectibix (2006) Inlyta (2012) Zydelig (2014)
Each drug costs $3,000 - $11,000 per month

CANCER PROTOCOL
Angiostop
Revivin
Reishi Spore Extract
Asparagus Extract
Myomin
(Hormone-related cancer)
ANGIOSTOP
Angiogenesis
inhibitor
Induces apoptosis
RTK inhibitor:
VEGFR, EGFR,
Sea Cucumber Extract
PDGFR, FGFR

Bioactive Compounds from Sea Cucumber
Philinopside A Echinoside A Frondoside A
Inhibits 4 RTKs: VEGFR, EGFR, PDGFR, FGFR

Inhibits Topoisomerase2 alpha

Angiostop can inhibit all 4 RTKs and Associated
Cancer Processes
VEGFR PDGFR EGFR FGFR
(Avastin, Nexavar, (Gleevec, Sutent, (Tarceva, Erbitux, (Votrient, Stivarga)
Sutent, Votrient, Nexavar, Sprycel, Herceptin, Iressa,
Zactima, Inlyta, Inlyta, Votrient, Tykerb, Zactima,
Caprelsa, Stivarga) Stivarga) Caprelsa)
Angiogenesis
Proliferation
Apoptosis
Lymphomagenesis
Tumor Vascular

Maturation
Mitogenesis
Cellular motility
Metastasis

Angiostop (Sea Cucumber) References
Inhibits human breast cancer (95%) cell survival,
migration, invasion
Suppresses lung cancer (88%) cell survival, tumor
growth, angiogenesis, invasion, metastasis
Reduced prostate carcinoma growth
Induces apoptosis in pancreatic cancer cells
Inhibits melanoma (90%) cells and liver cancer (95%)
Marine Drugs. 2004; 2: 185-191. Annals of the New York Academy of Sciences. 2008; 1138:181-98.
Natural Product Research. 2006; 20(4): 399-407. Journal of Medicinal Food. 2008;11(3):443-53.
Helvetica Chimica Acta. 2006; 89: 54-63. European Journal of Pharmacology. 2011;668(1-2):25-34.
International Journal of Cancer. 2005; 114: 843-853. Breast Cancer Research and Treatment. 2012; 132(2): 1001-1008.
Cancer Biology & Therapy. 2005; 4(8): 874-882. International Journal of Oncology. 2012; 41(3):933-40.
Townsend Letter. 2006 Aug/Sep: 91-95. Molecules. 2013; 18(7): 7886-909.
Intl Journal of Integrative Oncology. 2008; 2(1):7-15. PLoS One. 2013;8(1): e53087.
Annals of Oncology. 2010 ;21(3):597-607. Natural News. Oct 15, 2013.
Nutritional Perspectives: J ACACN. Jan 2013; 36(1):5-12. Eur J Cancer. 2014 May;50(7):1391-8.

Angiostop inhibits 4 RTKs and associated cancer types
(Tarceva, Erbitux, (Votrient,
Type of Cancer (Avastin, Nexavar, Sutent,
Votrient, Zactima, Inlyta,
(Gleevec, Sutent, Nexavar,
Sprycel, Inlyta, Votrient,
Herceptin, Iressa, Stivarga)
Tykerb, Zactima,
Caprelsa, Stivarga) Stivarga)
Caprelsa)
Bladder
Bone
Brain (Glioma)
Breast
Colorectal
Esophageal
Gastric
Head and Neck
Kidney
Leukemia
Liver

Angiostop inhibits 4 RTKs and associated cancer types
Type of Cancer (Avastin, Nexavar, Sutent, (Gleevec, Sutent, Nexavar, (Tarceva, Erbitux, (Votrient,
Votrient, Zactima, Inlyta, Sprycel, Inlyta, Votrient, Herceptin, Iressa, Tykerb, Stivarga)
Caprelsa, Stivarga) Stivarga) Zactima, Caprelsa)
Lung
Lymphoma
Melanoma
Meningioma
Myeloma
Nasopharyngeal
Ovarian
Pancreatic
Prostate
Thyroid

BREAST CANCER
F. Akbarpour, MD from CA, has an 81 y/o/f patient
with breast cancer. She had a mastectomy but the
cancer recurred as angiosarcoma in the breast.
Sutent (25 mg/day) had no effect. The dose was
doubled but still no apparent effect. Then the Sutent
dose was reduced and Angiostop was added. After
3-4 months the angiosarcoma cleared.
Sutent only for VEGFR. Breast cancer expresses VEGFR,

EGFR, and FGFR. Angiostop inhibits all 3 RTKs.

Cancer recurrence rate increases after surgery
Breast Cancer Colon and Lung Cancer
Study : 1,173 breast cancer patients Lung and colon cancer surgery linked
treated with surgery, 520 had relapse to cancer recurrence.
(20% of premenopausal women relapsed
within 10 months after surgery). Colon cancer patients who had surgery
had higher relapse rate than invasive
Source: Intl J Surgery. 2005. laparoscopy
Source: Lancet. 2002.
Chance of recurrence and metastasis after surgery:

Within 2 years 50%
After 5 years 5%
Recommendation: Use an angiogenesis inhibitor like Angiostop
before and after surgery to help minimize recurrence

First-Line Treatment with VEGFR Inhibitor
(Avastin) produces better results
Median Overall One-year Avastin
Type Treatment Survival survival Cost/
(months) rate (%) month
Colorectal 5-FU,
cancer irinotecan,
20.3 51.9 $4,000
(first-line leucovorin +
treatment) bevacizumab
Colorectal 5-FU,
cancer irinotecan,
(second-line oxaliplatin + 12.9 7.2 $8,000
treatment) bevacizumab
(high dose)
Source: May 2005 Annual Meeting of the American Society of Clinical Oncology and Skin and
Allergy News. July 2005, p.6

ANGIOSTOP
Multiple RTK targets (VEGFR, EGFR, PDGFR,
FGFR): more effective
Topoisomerase2 inhibitor
Should use as first-line treatment
Should be used before and after surgery and biopsy to
reduce recurrence
Use by itself or with chemo for synergistic effects
Reasonable cost compared to cancer drugs
Sources: Journal of Thoracic Oncology. 2006 1:890.
Journal Clinical Investigation. 2003; 111:1287-1295.
FASEB Journal. 2004; 18:338-340.

Angiostop vs.Topoisomerase2 Drugs
Inserts into DNA double strands and reduces
noncovalent binding of Top2 to DNA, less toxicity
Study: Human PROSTATE CANCER (PC-3)

xenograft model
Group T/C (%)
Mitomycin C, 5 mg/kg (positive control) 38.9
Angiostop, 2.6 mg/kg 53.7
Angiostop, 5.2 mg/kg 45.1
More Top2 drugs: Etoposide, Adriamycin and Vincristine

Source: Annals of Oncology. 2010 ;21(3):597-607.

TARGETS FOR ANTI-CANCER AGENTS
Inhibition of growth factor signaling
ANGIOSTOP
REVIVIN EGFR, PDGFR, VEGFR, FGFR
Induction of Inhibition of signal

apoptosis transduction pathway
intermediates
AKT
Nuclear
Inhibition of DNAs membrane
topoisomerase2
Inhibition of G1-S transition
G1 S
Cell
membrane
REVIVIN
Inhibits G1-S transition in Cell Cycle
A disruption in the cell cycle can cause the cell to multiply
uncontrollably, forming a tumor.
Uncontrolled cell
replication is inhibited
Ensures that damaged or
mutated DNA does not
get passed on to daughter
cells
LD50: 10.0g/kg
REVIVIN
G1-S Inhibitor
O
HO Fritillaria
O OAc Immunity
OH
Nodules
HO
Lung, breast,
Active Ingredient thyroid
HO in Revivin

Revivin suppressed Glioblastoma
U87MG cells in mice at IC50 of 3.6 M
Glioblastoma most common type of
malignant brain tumor
Revivins anti-tumor property may be due to
Induction of apoptosis
Induction of cell cycle arrest (G1-S inhibition)
Sources: Bioorganic & Medicinal Chemistry Letters. 2006; 16(17):4575-80.

Chinese Journal of Cancer. 2002; 21(4):346-50.

BRAIN CANCER
A. Sayler, CN from FL, has a 52 y/o/m patient with

Stage 4 brain cancer (blastoma astrocytoma).
Surgery removed a golf ball-sized tumor but ~1cm
of the tumor remains. He underwent 42 radiation
treatments and then added Angiostop and Revivin.
He also went through 48 courses of chemotherapy.
After 2 years, his doctor declared that he has
never seen such excellent results!

COLON CANCER
J. Blair, ND from NJ, has a 55 y/o/m patient

with inoperable stage 4 colon cancer and lung
tumor. After 8 months of chemo, he lost 87 lbs
and was given 2 months to live. In Aug 2010, he
started taking Angiostop, Revivin, OxyPower. In
Feb 2011, the lung tumor shrank by 25% and he
gained back 53 lbs. In Aug 2011, his colon
cancer is completely gone and hes back at his
regular job.

PANCREATIC CANCER
Abby Sayler, CN from FL, reports on
Simi L., a 66 y/o/f patient with pancreatic
cancer who had tremendous progress after
taking Angiostop, Revivin and Reishi
Spore Extract. Simis phone number is
(813) 787-0366. Simi Abby
Date Tumor size Notes

Started chemo and later radiation.
3/21/13 4.8 x 3.9 cm
Stopped both on 5/30/13
7/12/13 4.0 x 3.5 cm Started Angiostop, Revivin, Reishi
11/1/13 2.7 x 2.5 cm
Tumor reduced in size 8 months after
3/14/14 2.0 x 1.2 cm
starting the supplements
METASTATIC PANCREATIC CANCER
F. Akbarpour, MD from CA, has a 78 y/o/m
patient with pancreatic cancer metastasized to
the liver and lungs.
Feb 2010 CEA was 210
Two liver specialists from UC San Francisco and
UCLA have already determined that treatment
would be impossible
Apr 2010 Started Angiostop, Revivin
Jul 2010 CEA dropped to 11
May 2011 Declared cancer-free

Bone Marrow or Blood Disease
(Lymphoma, Leukemia, Anemia, etc.)
Shell-Shaped/Triangular Nails
Whenever you have these nails, check your Hgb, WBC, RBC levels

BLOOD DISEASE (HIGH PLATELETS)
T. Callaghan, MD from MS, has a 65 y/o/f patient who had
very high platelets for 10 years. Hematologist gave 5-FU
to no avail. Beginning Nov 2011, she took Angiostop,
Revivin, Reishi Spore Extract, and Asparagus Extract.
Test 11/9/2011 2/9/2012 3/9/2012 Reference

13.4 6.9 7.2
WBC High Normal Normal 4.6 10.2 K/uL
10.7 11.9 12.2

Hemoglobin Low Improved Normal 12.2 16.2 g/dL
1243.0 402.0 277.0

Platelets High Normal Normal 142.0 424.0 K/uL

ASPARAGINASE
Asparaginase from Asparagus: Most powerful
healing food
Listed in the USP Drug Information book (1998.
18:3213,3215) as treatment for:
Acute Lymphocytic Leukemia (ALL)
Chronic lymphocytic leukemia (CLL)
Acute Myelomonocytic Leukemia
Acute Myelocytic Leukemia (AML)
Hodgkins Lymphoma
Non Hodgkins Lymphoma

LEUKEMIA
Moffit Cancer Center (FL): A 61 y/o/m has

Chronic Lymphocytic Leukemia (CLL).
After taking Angiostop and Asparagus
Extract for 6 months, his WBC level has
dropped significantly to 6,500.
Serum test Before After 6 months
WBC 144,000 6,500

NAIL CLUBBING
Cancer
Lung cancer
(opaque nails)
Lymphoma
Leukemia
Breast cancer
Copyright. Chis Enterprise, Inc. Colon cancer, etc

Nail clubbing and Cancer
Total # of # cases w/
Neoplastic Diseases %
cases clubbing
Mesothelioma
77 23 29.9
(from asbestosis)
Bronchogeneic carcinoma 111 32 28.9
Pleural Tumors 21 3 14.3
Lymphoma 40 6 15
Intrathoracic Hodgkins in
5 5 100
children
Nasopharyngeal carcinoma 90 6 6.7
Source: J American Academy of Dermatology. June 2005; 52(6): 1020-28

Estrogen and Aromatase May Play a
Role in Lung Cancer
Women have 3 times higher risk of developing lung cancer
than men
Lung carcinomas have estrogen receptors
EGFR Inhibitors Lung cancer survival by 10 months
Tarceva (EGFR inhibitor): resistance develops after 9
months
Lung cancer expresses EGFR, VEGFR, PDGFR and
FGFR so they all need to be inhibited
Must use Angiostop and Myomin
Sources: Chinese World Journal Daily News. Nov 9, 2010: F2.
Medical Hypothesis. 2011; 76(3):328-31.
Steroids. 2011 Mar 30 epub. Cancer. 2011; 117(6):1288-95.

LUNG CANCER
Antoine E., a 58 y/o/m from FL, had Stage I
small cell lung cancer. He underwent surgery,
chemo and radiation but it recurred as Stage 4
inoperable lung cancer and given 6 months to
live. In April 2011, he started Angiostop (12
capsules), Revivin, Reishi Spore, Asparagus,
Myomin and Oxypower. In March 2013, his
cancer cleared. He can be reached at
(813) 226-2345.

LUNG CANCER
M. Smith, MD from FL, has a 78 y/o/f patient, Copyright. Chis Enterprise, Inc.
Anne, with lung cancer. She had surgery,

chemotherapy and radiation. In 2012, masses
were found in her lungs. In Oct 2012, she started
Angiostop, Revivin, Myomin and OxyPower.
Three months later, the nodule in her upper right Anne
lobe reduced to 2.4x1.8 cm2. A year later, it
reduced to 1 x 1.8cm2. Annes contact number is
(813) 253-3040.
Date 4/22/2013 3/21/2014 7/31/2014
Tumor size 2.4 x 1.8 cm2 1 x 1.8 cm2 Stabilized
SUV 3.4 1.9

LUNG CANCER
Kongma P., 57 y/o/f from CA, has NSCLC.
Both her brother and sister used chemo,
radiation and Tarceva and died within 2-3
years. Now she is much better. Her phone
number is (562) 698-9161.
Left lung Right lung
Date Notes
tumor tumor
2007 Surgery Stage I lung cancer
9/20/2012 10mm 14mm Stage IV lung cancer
Started Angiostop, Revivin,
7/2013 13mm 17mm
Tarceva, Vitamin C
2/2014 10mm 14mm Angiostop, Revivin, Tarceva
8/2014 Cancer stabilized Angiostop, Revivin, Tarceva

For Estrogen-Dominant Cancer
Breast Cancer, Prostate Cancer, Ovarian Cancer,
Uterine Cancer, Endometrial Cancer, Cervical
Cancer, Testicular Cancer
MYOMIN Aromatase reducer

ANGIOSTOP Angiogenesis/RTK
inhibitor
REVIVIN G1-S inhibitor
HER2+ BREAST CANCER
F. Akbarpour, MD from CA, has a 70 y/o/f

patient diagnosed with breast cancer. She took
Herceptin and underwent chemo. Despite that,
the cancer metastasized to the liver, lung and
bones. Then she added Angiostop and
Myomin. Two years later, her cancer cleared.
Breast cancer expresses VEGFR, EGFR and FGFR so

EGFR inhibitor like Herceptin is not enough.

ER+ BREAST CANCER
D. Norowitz, MD from NY, has a 63 y/o/f patient
with ER+ breast cancer that has metastasized to the
bones (pelvic, rib and thoracic area). In Sep 2011,
she started taking Femara with Angiostop, Myomin
and Revivin. In Feb 2012, a PET/CT scan showed
that the cancer in the rib and thoracic area has
completely resolved while the cancer in the pelvic
area has significantly reduced.
Femara is an aromatase inhibitor and is not good for bone

cancer. Angiostop blocks all 4 RTKs in bone cancer.

Earlier detection of Ovarian Cancer
Frequency of occurrence Symptoms and risk
Symptom
in ovarian cancer cases factors:
Fatigue 34% Family history of
Low back pain 45% breast and ovarian
Bloating 27% cancer
Constipation 24% Red dots on the
Abdominal pain 22% tongue
Urinary symptoms 16% Cherry angiomas in
trunk
Ultrasound and CA-125 screening 75% too late

Cancer has progressed to stage 4 and metastasized
Increased mortality
Source: Family Practice News. January 15, 2005.

ENDOMETRIAL DYSPLASIA
I. Wilkins, MD from PA, has a 67 y/o/f patient taking
Myomin, Angiostop and Revivin since August 2012 for
thick endometrial lining and possible endometrial polyp.
After 6 months, a recent pelvic ultrasound revealed
tremendous improvement.
Description 8/17/2012 2/21/2013 % change

Uterus (mm3) 63 x 7 x 44 52 x 32 x 38 38.3
Endometrial lining 7.7 3.7 52.0
Endometrial cavity
13 x 7 x 11 6x2x6 92.8
(echogenic mass)

ENDOMETRIAL METAPLASIA
J. Iannetta, DC from ME, has a 57 y/o/f postmenopausal
patient who has endometriosis with tubular metaplasia and
polyps. A sudden vaginal bleeding was suspected to be
ovarian/uterine cancer so she took Myomin and Angiostop
right away. After 14 months, both her estradiol and
CA.125 level (ovarian cancer marker) reduced.
Serum test 8/2007 10/2008 9/2010
Estradiol (pg/ml) 413 43 < 32

(Normal)
CA.125 (U/ml) 30 4.6 --

OVARIAN CANCER
R. Rozich, DC from IL, has a 54 y/o/f patient, E.M.,
who was diagnosed with ovarian cancer in Feb
2012. She started taking Angiostop, Myomin and
Revivin a month before her surgery.
Feb 2012 Mar 2012 Apr 2013

CA.125 427 190 4
Patient Contact # Surgery then chemo until July 2012

(815) 744-1511 Continued with Angiostop, etc.

PROSTATIC EPITHELIAL
HYPERPLASIA
K. Greenawalt, DC from VA, has a 59

y/o/m prostate cancer patient with PSA
level of 12 six years ago. About 6 months
after taking Angiostop and Myomin, his
PSA dropped to 6. Another six months
later, his PSA further dropped to 3.06.

R. Brassard, DC, former president of Texas
Chiropractic College and current Chairman
of the Japan Chiropractic Association, has a
71 y/o/m patient whose PSA reduced to 1.2
after a year on Myomin, Angiostop, Kidney
Chi and Prosta Chi.
Before After 1 year Reference

PSA 7.8 1.2 < 4.0

KIDNEY CANCER
R. Abraham, MD from CA, has a male
patient in his 60s with kidney cancer. He
used Sutent, which reduced his tumor to
only 2cm. Then Angiostop and Revivin were
added. After 3-4 months, the tumor reduced
to 1cm. After a year, the tumor is gone.
Sutent inhibits VEGFR and PDGFR only. Kidney cancer
expresses VEGFR, PDGFR and FGFR. So Angiostop is
needed to suppress FGFR.

BLADDER TUMORS
A. Sayler, CN from FL,

reports on Robert, a 65
y/o/m patient, a former
smoker who had bloody
urine (with no pain). An
ultrasound revealed 4 tumors
in the bladder, ranging in
Roberts phone: (813) 443-6095 size from a quarter to a half
dollar. Surgery was
recommended but instead he took Angiostop Revivin and
Metal Flush. Over four months later, the tumors cleared.

TONGUE / ORAL CANCER
Dr. Wolfe, MD, has a 70 y/o/m patient diagnosed with
squamous cell carcinoma on his tongue and had the
cancer removed. A very large tumor was found on his
neck 9 months later and was removed again. He then
had 6 radiation treatments but
could not stand the side effects.
Then R. Welch, DC from CA,
suggested Angiostop, Revivin,
Asparagus Extract, etc. for
1 years. Later Dr. Wolfe Copyright. Chis Enterprise, Inc.
examines R.C. and reports that the cancer had cleared.

ESOPHAGEAL CANCER
D.P., a 49 y/o/m from FL, has had stage 4

esophageal cancer for 8 years. At the time
of diagnosis, he underwent chemo and
radiation and was given 1 year to live.
Then he started Angiostop, Revivin, and
Reishi Spore. A recent test showed that his
cancer has cleared.

COLON AND LUNG CANCER
2011 Male at age 64, Blood in stool. No insurance. Took Angiostop, Revivin.
Sep 2012 At age 65, got insurance. Diagnosed with lung cancer (smoker)
removed upper left lung (2cm NSCLC). Oncologist amazed it did not metastasize.
Mar 2013 Diagnosed with colon cancer removed 2 sections
No chemotherapy or radiation. Only took Angiostop, Myomin, Revivin.
3/12/13 6/28/13 12/5/13 1/3/14 4/9/14 6/11/14 Ref

CEA 5.6 6.2 7.6 7.6 9.0 7.9 < 5.0 ng/ml
(smokers)
Took 6-8 capsules Took Angiostop (4 caps only) Back to 8 capsules

Angiostop Angiostop
Must use 8-9 capsules daily of Angiostop for cancer

April 2012 lecture to cancer patients, cancer
survivors and healthcare professionals in Hawaii

CONTACT
CHIS ENTERPRISE, INC.
1435 N. Brasher Street
Anaheim, CA 92807
(714) 777-1542
www.chi-health.com


DrChi PART 1 October3

Transféré par

Informations du document

Copyright

Formats disponibles

Partager ce document

Partager ou intégrer le document

Options de partage

Avez-vous trouvé ce document utile ?

Ce contenu est-il inapproprié ?

Droits d'auteur :

Formats disponibles

DrChi PART 1 October3

Transféré par

Droits d'auteur :

Formats disponibles

FINGERNAIL AND

October 3, 2014 Anchorage, Alaska

Tsu-Tsair Chi, NMD, PhD

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

the reemergence of interest in hands on

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

* Later verified by medical tests

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

72% physicians and 89% nurses use dietary

Copyright. Chis Enterprise, Inc.

50% Interested to try CAM

Conventional medicine would not help

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc. 15

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

If present for more than a month

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.

Anemia Copyright. Chis Enterprise, Inc.

Copyright. Chis Enterprise, Inc.